» Articles » PMID: 33042025

Serum Trace Elements in Patients With Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis

Overview
Specialty Endocrinology
Date 2020 Oct 12
PMID 33042025
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Polycystic ovary syndrome (PCOS) is reported to be associated with certain trace elements. However, previous data are inconsistent and potentially biased due to small sample sizes. The potential utility of trace element levels for screening of PCOS remains to be established. The aim of this meta-analysis was to investigate the potential relationships between PCOS and serum levels of zinc (Zn), copper (Cu), magnesium (Mg), iron (Fe) and ferritin. We carried out a literature search of PubMed, EMBASE, and Web of Science for relevant cross-sectional/case-control studies published prior to October 2019. Random-effect models were used to estimate the overall standard mean differences (SMDs) between PCOS and healthy control subjects. The screening value of potential microelement biomarkers for PCOS was assessed using the receiver operating characteristic (ROC) curve. Twenty-one studies featuring 2,173 women with PCOS and 1,897 healthy women were selected for analysis. Our results showed that Cu and ferritin levels were significantly higher in women with PCOS than healthy controls, with SMDs of 0.52 [95% confidence interval (CI): 0.38-0.67, = 47.6%] and 1.05 (95% CI: 0.25-1.86, = 97.0%), respectively. The serum ferritin concentration was distinguished as a potential biomarker for PCOS based on the high area under ROC curve value of 0.71 (95% CI: 0.57-0.86). Although we did not identify a statistical association between serum Zn concentration and PCOS overall, the concentration of Zn in PCOS women with insulin resistance (IR) was lower than that in healthy women (SMD = -0.89, 95% CI: -1.73 to -0.06). Furthermore, the concentrations of Mg (SMD = 0.31, 95% CI: -0.32-0.94, = 95.4%) and Fe (SMD = -0.59, 95% CI: -1.29-0.12, = 97.2%) were not statistically significant between the PCOS and control groups. We generated hypothetical pathways for associations among serum Cu, ferritin and PCOS. The serum concentrations of both Cu and ferritin were significantly higher in women with PCOS, and ferritin was identified as a potential early indicator for PCOS screening. Further studies are essential to determine the specific underlying mechanisms.

Citing Articles

Link between iron-mediated lipid peroxidation and polycystic ovary syndrome (PCOS): exploring the genes underlying iron regulatory mechanism.

Hayat N, Akram Z, Khalid N, Ullah N, Mazhar T J Ovarian Res. 2025; 18(1):48.

PMID: 40057801 PMC: 11889770. DOI: 10.1186/s13048-024-01562-6.


Association of hemoglobin levels with metabolic traits in women with PCOS.

Virtanen N, Pesonen E, Saarela U, Hurskainen E, Arffman R, Koivunen P Acta Obstet Gynecol Scand. 2024; 104(2):357-367.

PMID: 39740096 PMC: 11782057. DOI: 10.1111/aogs.15047.


Oxidative stress and energy metabolism abnormalities in polycystic ovary syndrome: from mechanisms to therapeutic strategies.

Yan H, Wang L, Zhang G, Li N, Zhao Y, Liu J Reprod Biol Endocrinol. 2024; 22(1):159.

PMID: 39722030 PMC: 11670460. DOI: 10.1186/s12958-024-01337-0.


Differences in cardiovascular disease mortality between northern and southern China under exposure to different temperatures: a systematic review.

Zhai G, Jiang Z, Zhou W PeerJ. 2024; 12:e18355.

PMID: 39494270 PMC: 11531265. DOI: 10.7717/peerj.18355.


Polycystic Ovary Syndrome and Ferroptosis: Following Ariadne's Thread.

Geronikolou S, Pavlopoulou A, Koutelekos I, Kalogirou D, Bacopoulou F, Cokkinos D Biomedicines. 2024; 12(10).

PMID: 39457593 PMC: 11505293. DOI: 10.3390/biomedicines12102280.


References
1.
Jamilian M, Foroozanfard F, Bahmani F, Talaee R, Monavari M, Asemi Z . Effects of Zinc Supplementation on Endocrine Outcomes in Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial. Biol Trace Elem Res. 2015; 170(2):271-8. DOI: 10.1007/s12011-015-0480-7. View

2.
Hossein Rashidi B, Shams S, Shariat M, Kazemi Jaliseh H, Mohebi M, Haghollahi F . Evaluation of serum hepcidin and iron levels in patients with PCOS: a case-control study. J Endocrinol Invest. 2017; 40(7):779-784. DOI: 10.1007/s40618-017-0632-z. View

3.
Wan X, Wang W, Liu J, Tong T . Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014; 14:135. PMC: 4383202. DOI: 10.1186/1471-2288-14-135. View

4.
Jamilian M, Sabzevar N, Asemi Z . The Effect of Magnesium and Vitamin E Co-Supplementation on Glycemic Control and Markers of Cardio-Metabolic Risk in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial. Horm Metab Res. 2018; 51(2):100-105. DOI: 10.1055/a-0749-6431. View

5.
Palomba S, de Wilde M, Falbo A, Koster M, La Sala G, Fauser B . Pregnancy complications in women with polycystic ovary syndrome. Hum Reprod Update. 2015; 21(5):575-92. DOI: 10.1093/humupd/dmv029. View